Delivery Order SPE2DB20D1100-SPE2DB24FC1A8

Award Date 6/4/24
Potential Completion Date 6/5/24
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,530,533 CARVEDILOL ER 80 MG CAPSULE 30S to the Defense Logistics Agency (DLA). The Firm Fixed Price contract, valued at $2,663.92, has an ultimate completion date of May 8, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is delivering these prescription medications under a $999,999,999.00 Indefinite Delivery Contract with the DLA Troop Support Medical. This...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564766493 CARVEDILOL ER 20 MG CAPSULE 30S. The contract has a ceiling value of $1,228.41 and an ultimate completion date of June 3, 2024. It is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563867825 CARVEDILOL ER 20 MG CAPSULE 30S. The contract has a completion date of March 6, 2024 and a potential value of $13,305.40. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA Troop Support Medical, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $3,939.61 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of CARVEDILOL ER 80 MG CAPSULE 30S. This Firm Fixed Price contract has a completion date of May 23, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a comprehensive range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,994.45 firm fixed-price delivery order is for the supply of 4564689424 - CARVEDILOL ER 80 MG CAPSULE 30S, with a completion date of May 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025, under which it...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,640.78 firm fixed-price contract is for the supply of 4565534064 - CARVEDILOL ER 20 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of August 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of CARVEDILOL ER 40 MG CAPSULE 30S to the Defense Logistics Agency (DLA), a defense agency. The fixed-price delivery order has a ceiling value of $1,164.05 and an ultimate completion date of June 20, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of CARVEDILOL ER 20 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $3,487.54 and a completion date of August 26, 2024. This appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of CARVEDILOL ER 20 MG CAPSULE 30S. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,840.42 firm fixed-price delivery order is for the supply of 4567089340 - CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. The contract has an ultimate completion date of January 30, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC1A8
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564802606 CARVEDILOL ER 20 MG CAPSULE 30S medication to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $4,826.43 and a completion date of June 5, 2024. This is a delivery order contract with a firm fixed-price pricing type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Generated 9/3/24, 11:59 AM